Entering into an Alliance with Big Pharma: Benchmarks for Drug Delivery Contract Service Providers

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-10-02-2001, Volume 25, Issue 10

The author proposes a strategy for achieving a successful partnership with Big Pharma on the basis of forming a relationship with the company, deliberately managing the alliance, and clearly defining roles and responsibilities.

Related Content:

Drug DeliveryOutsourcingDevelopmentPharmaceutical Technology-10-02-2001
EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease
Newly Opened Innovation Center in New Jersey Gives Avantor Advantage in Solving Life Sciences Challenges
Avantor Sees Future of Opportunities with Growing Development of Next-Gen Biotherapeutics